| Customization: | Available |
|---|---|
| Certification: | ISO, CE |
| Disinfection: | Disinfection |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Patients with a history of anaphylaxis or severe allergy symptoms.
Pregnant or breast feeding women.
The site previously applied with other product.
Patients who are or have been hypersensitive to hyaluronic acid.
Patients who have been hypersensitive to raw materials of filler.
To increase the volume of the breasts.
The young people less than 18 years old.
The bones, tendons and ligaments.
Pregnancy & Lactation
Product should not be used for Pregnant or breast feeding women.
Precautions
Elravie is associated with an inherent risk of infection
Elravie should not be used at or near anatomic site with active skin disease, inflammation or related condition.
While patients are taking non-steroidal anti-inflammatory drugs such as acetaminophe n, the injection of the product can increase a bruising at the injection site and inject carefully in inevitable situation.
Elravie should be checked before being used and it should not be used if abnormal.
Injection procedures can lead to reactivation of latent or asymptomatic herpes infections.
){kind=link}